Related references
Note: Only part of the references are listed.SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b
Sita Kugel et al.
CELL (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma A Paradigm Shift to Reduce Overtreatment of Indolent Tumors
Yuri E. Nikiforov et al.
JAMA ONCOLOGY (2016)
Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer
K-F Hsu et al.
BRITISH JOURNAL OF CANCER (2015)
Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors
Robin L. Jones et al.
CLINICAL CANCER RESEARCH (2015)
A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors
Igor Puzanov et al.
CLINICAL CANCER RESEARCH (2015)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer
Marcell Lederer et al.
SEMINARS IN CANCER BIOLOGY (2014)
The landscape of kinase fusions in cancer
Nicolas Stransky et al.
NATURE COMMUNICATIONS (2014)
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Jessica L. Bell et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Overcoming IGF1R/IR Resistance through Inhibition of MEK Signaling in Colorectal Cancer Models
Sara A. Flanigan et al.
CLINICAL CANCER RESEARCH (2013)
The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors
Giorgio V. Scagliotti et al.
CANCER TREATMENT REVIEWS (2012)
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer
Paul Lochhead et al.
EUROPEAN JOURNAL OF CANCER (2012)
Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?
Douglas Yee
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression
Sofia Asioli et al.
MODERN PATHOLOGY (2010)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas
Norbert Drieschner et al.
GENE (2007)
The insulin-like growth factor system and cancer
D LeRoith et al.
CANCER LETTERS (2003)
Translocations involving c-myc and c-myc function
LM Boxer et al.
ONCOGENE (2001)
Share Paper
